Search research articles
Contact Us
Filters
Showing results (41-50 of 103) with videos related to
Page
of 11
Sort By:
Schizophrenia Research
|
May 26, 2007
Neurotrophins and schizophrenia
Peter F Buckley, Sahebarao Mahadik, Anilkumar Pillai, et al.
International Review of Psychiatry (Abingdon, England)
|
June 17, 2006
Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia
Sahebarao P Mahadik, Anilkumar Pillai, Sadhana Joshi, et al.
Neurobiology of Disease
|
May 11, 2010
An inverse relationship between cortisol and BDNF levels in schizophrenia: data from human postmortem and animal studies
George Issa, Christina Wilson, Alvin V Terry, et al.
Mitochondrion
|
September 3, 2021
Mitophagy in depression: Pathophysiology and treatment targets
Ashutosh Tripathi, Giselli Scaini, Tatiana Barichello, et al.
Schizophrenia Research
|
July 24, 2014
Cysteamine, a pro-BDNF drug, as an adjunctive treatment for schizophrenia
Peter F Buckley, Brian J Miller, Anilkumar Pillai, et al.
Journal of Geriatric Care and Research
|
April 16, 2019
Galantamine-memantine combination superior to donepezil-memantine combination in Alzheimer's disease: critical dissection with an emphasis on kynurenic acid and mismatch negativity
Maju Mathew Koola, Agnieszka Nikiforuk, Anilkumar Pillai, et al.
Journal of Psychiatric Research
|
March 28, 2006
Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain
Anilkumar Pillai, Vinay Parikh, Alvin V Terry, et al.
International Immunopharmacology
|
July 4, 2025
Innate immunity in the brain: ILC2s as modulators of CNS disorders
Jyotsna D Godavarthi, Anilkumar Pillai, Rodrigo Morales, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
August 19, 2016
Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?
Robert A Stockley, Ross G Edgar, Anilkumar Pillai, et al.
Schizophrenia Research
|
February 20, 2007
Brain derived neurotropic factor in first-episode psychosis
Peter F Buckley, Anilkumar Pillai, Denise Evans, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 103) with videos related to
Sort By:
Page
of 11
Schizophrenia Research
|
May 26, 2007
Neurotrophins and schizophrenia
Peter F Buckley, Sahebarao Mahadik, Anilkumar Pillai, et al.
International Review of Psychiatry (Abingdon, England)
|
June 17, 2006
Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia
Sahebarao P Mahadik, Anilkumar Pillai, Sadhana Joshi, et al.
Neurobiology of Disease
|
May 11, 2010
An inverse relationship between cortisol and BDNF levels in schizophrenia: data from human postmortem and animal studies
George Issa, Christina Wilson, Alvin V Terry, et al.
Mitochondrion
|
September 3, 2021
Mitophagy in depression: Pathophysiology and treatment targets
Ashutosh Tripathi, Giselli Scaini, Tatiana Barichello, et al.
Schizophrenia Research
|
July 24, 2014
Cysteamine, a pro-BDNF drug, as an adjunctive treatment for schizophrenia
Peter F Buckley, Brian J Miller, Anilkumar Pillai, et al.
Journal of Geriatric Care and Research
|
April 16, 2019
Galantamine-memantine combination superior to donepezil-memantine combination in Alzheimer's disease: critical dissection with an emphasis on kynurenic acid and mismatch negativity
Maju Mathew Koola, Agnieszka Nikiforuk, Anilkumar Pillai, et al.
Journal of Psychiatric Research
|
March 28, 2006
Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain
Anilkumar Pillai, Vinay Parikh, Alvin V Terry, et al.
International Immunopharmacology
|
July 4, 2025
Innate immunity in the brain: ILC2s as modulators of CNS disorders
Jyotsna D Godavarthi, Anilkumar Pillai, Rodrigo Morales, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
August 19, 2016
Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?
Robert A Stockley, Ross G Edgar, Anilkumar Pillai, et al.
Schizophrenia Research
|
February 20, 2007
Brain derived neurotropic factor in first-episode psychosis
Peter F Buckley, Anilkumar Pillai, Denise Evans, et al.
Page
of 11